Molina Healthcare Reports Fourth Quarter and Year-End 2022 Financial Results

By: Molina Healthcare, Inc. via Business Wire

February 08, 2023 at 16:15 PM EST

Introduces Full-Year 2023 Revenue and Earnings Guidance

Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported fourth quarter 2022 GAAP earnings per diluted share of $0.96 and adjusted earnings per diluted share of $4.10. The Company also reported full year 2022 GAAP earnings per diluted share of $13.55 and adjusted earnings per diluted share of $17.92. Financial results are summarized below.

	Quarter ended		Year ended
	December 31,		December 31,
	2022	2021	2022	2021

(In millions, except per-share results)
Premium Revenue	$7,917	$7,166	$30,883	$26,855
Total Revenue	$8,223	$7,409	$31,974	$27,771

GAAP:
Net Income	$56	$103	$792	$659
EPS – Diluted	$0.96	$1.74	$13.55	$11.25
Medical Care Ratio (MCR)	88.3%	88.8%	88.0%	88.3%
G&A Ratio	7.6%	7.8%	7.2%	7.4%
After-tax Margin	0.7%	1.4%	2.5%	2.4%

Adjusted:
Net Income	$240	$170	$1,048	$793
EPS – Diluted	$4.10	$2.88	$17.92	$13.54
G&A Ratio	7.5%	7.4%	7.1%	7.2%
After-tax Margin	2.9%	2.3%	3.3%	2.9%
See the Reconciliation of Unaudited Non-GAAP Financial Measures at the end of this release.

Full Year Highlights

As of December 31, 2022, the Company served approximately 5.3 million members.
Premium revenue was $30.9 billion for the full year 2022, an increase of 15% year over year.
GAAP earnings were $13.55 per diluted share, an increase of 20% year over year. GAAP earnings include a fourth quarter non-cash, after tax impairment charge of $159 million, or $2.72 per diluted share, attributable to the Company’s plan to reduce its leased real estate footprint.
Adjusted earnings were $17.92 per diluted share, an increase of 32% year over year.
The Company issued its full year 2023 earnings guidance with expected premium revenue of $32 billion and adjusted earnings of at least $19.75 per diluted share. Earnings guidance includes $0.65 per diluted share of one-time, non-recurring, implementation costs for new Medicaid contract wins.

“The fourth quarter completes another strong year of operating and financial performance,” said Joseph Zubretsky, President and Chief Executive Officer. “We are very pleased with our business performance during the year, as well as the progress we made in 2022 on our growth strategy, which has created a solid and growing financial profile as we head into 2023.”

Premium Revenue

Premium revenue was $30.9 billion for the full year, an increase of 15% compared to the full year 2021. The higher premium revenue reflects the impact of acquisitions and increased organic membership in the Medicaid and Medicare lines of business.

Net Income

GAAP net income for the full year was $13.55 per diluted share, compared to $11.25 per diluted share for the full year 2021. GAAP net income includes a fourth quarter non-cash, after tax impairment charge of $159 million, or $2.72 per diluted share, attributable to the Company’s plan to reduce its leased real estate footprint.

Adjusted net income for the full year was $17.92 per diluted share, compared to $13.54 per diluted share for the full year 2021, an increase of 32%. The net effect of COVID decreased full year 2022 GAAP and adjusted EPS by $2.50 per diluted share, compared to $3.50 per diluted share a year earlier.

Medical Care Ratio

The consolidated MCR for the full year was 88.0%, compared to 88.3% for the full year 2021. The full year consolidated MCR included a 60 basis point impact for the net effect of COVID, compared to 90 basis points for the full year 2021 MCR. The impact varied by segment.
The Medicaid MCR for the full year was 88.0%, at the low end of the Company’s long-term target range and consistent with pre-pandemic levels. Included in the full year MCR was a 10 basis point impact for the net effect of COVID.
The Medicare MCR for the full year was 88.5%, modestly above the Company’s long-term target range and included 300 basis points for the impact of the net effect of COVID.
The Marketplace MCR for the full year 2022 was 87.2%, above the Company’s long-term target range and included 120 basis points for the impact of the net effect of COVID.

General and Administrative Expense Ratio

The G&A ratio for the full year was 7.2%, compared to 7.4% for the full year 2021. The adjusted G&A ratio was 7.1% for the full year, compared to 7.2% for the full year 2021. The year over year improvement reflects disciplined cost management and the benefits of fixed cost leverage produced by the Company’s increase in revenue.

Balance Sheet

Cash and investments at the parent company were $375 million as of December 31, 2022, compared to $348 million as of December 31, 2021. The Company purchased approximately 590,000 shares for $200 million in the fourth quarter of 2022.

Days in claims payable at December 31, 2022 was 47, approximately three days lower sequentially. The decline was driven by an increased mix of long-term services and support claims which settle more quickly, resulting from the closing of the AgeWell acquisition, as well as an additional payment cycle in the quarter.

Cash Flow

Operating cash flow for the full year was $773 million, lower compared to the full year 2021. The decline compared to prior year was primarily due to the cash settlement in 2022 of large prior year Marketplace risk adjustment and Medicaid risk corridor payments.

2023 Guidance

Premium revenue for the full year is expected to be approximately $32 billion, an increase of approximately 4% from the full year 2022.

The Company expects its full year adjusted earnings per share in 2023 to be at least $19.75 per share, representing 10% growth over the full year 2022, with key metrics expected to be in line with the Company’s long-term targets. Excluding one-time non-recurring implementation costs for new Medicaid contract wins, adjusted earnings per share growth for the full year 2023 is expected to be 14%.

Guidance reflects expected:

Continued realization of embedded earnings;
Underlying organic growth and operational catalysts; and
$0.65 per diluted share of one-time non-recurring implementation costs for new Medicaid contract wins.

See the Reconciliation of Unaudited Non-GAAP Financial Measures at the end of this release.

Full Year 2023 Guidance ⁽¹⁾
Premium Revenue	$32.0B
Total Revenue	$33.0B
GAAP Net Income	$1,077M
Adjusted Net Income ⁽²⁾	$1,148M
GAAP EPS – Diluted	>$18.53
Adjusted EPS – Diluted ⁽²⁾	>$19.75
Diluted weighted average shares	58.1M

Year End Total Membership	5.1M
Medicaid	4.7M
Medicare	175K
Marketplace	230K

MCR	88.0%
GAAP G&A Ratio	7.0%
Adjusted G&A Ratio	7.0%
Effective Tax Rate	25.3%
GAAP After-tax Margin	3.3%
Adjusted After-tax Margin	3.5%
______________
(1) All amounts are rounded and approximations.
(2) Reconciliations of non-GAAP financial measures at the end of this release.

Conference Call

Management will host a conference call and webcast to discuss Molina Healthcare’s fourth quarter and full year 2022 results at 8:00 a.m. Eastern Time on Thursday, February 9, 2023. The number to call for the interactive teleconference is (877) 883-0383 and the confirmation number is 3561497. A telephonic replay of the conference call will be available through Thursday, February 16, 2023, by dialing (877) 344-7529 and entering confirmation number 8594444. A live audio broadcast of this conference call will be available on Molina Healthcare’s website, molinahealthcare.com. A 30-day online replay will be available approximately an hour following the conclusion of the live broadcast.

About Molina Healthcare

Molina Healthcare, Inc., a FORTUNE 500 company (currently ranked 125), provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. Molina Healthcare served approximately 5.3 million members as of December 31, 2022, located across 19 states. For more information about Molina Healthcare, please visit molinahealthcare.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

This earnings release and the Company’s accompanying oral remarks contain forward-looking statements regarding its 2023 guidance, including the Company’s plans and expectations regarding future developments. Actual results could differ materially due to numerous known and unknown risks and uncertainties. These risks and uncertainties are discussed under the headings “Forward-Looking Statements,” and “Risk Factors,” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, which is on file with the U.S. Securities and Exchange Commission (the “SEC”), and also in its Quarterly Reports on Form 10-Q for the periods ended March 31, 2022, June 30, 2022, and September 30, 2022, which are on file with the SEC. Additional information regarding the Company’s risk factors during 2023 and future periods will also be set forth in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, which the Company expects to file on or about February 13, 2023.

These reports can be accessed under the investor relations tab of the Company’s website or on the SEC’s website at sec.gov. Given these risks and uncertainties, the Company can give no assurances that its forward-looking statements will prove to be accurate, or that any other results or developments projected or contemplated by its forward-looking statements will in fact occur, and the Company cautions investors not to place undue reliance on these statements. All forward-looking statements in this release represent the Company’s judgment as of February 8, 2023, and, except as otherwise required by law, the Company disclaims any obligation to update any forward-looking statement to conform the statement to actual results or changes in its expectations.

MOLINA HEALTHCARE, INC.
UNAUDITED CONSOLIDATED STATEMENTS OF INCOME
	Three Months Ended						Year Ended
	December 31,						December 31,
	2022			2021			2022			2021

	*(In millions, except per-share amounts)*
Revenue:
Premium revenue	$	7,917		$	7,166		$	30,883		$	26,855
Premium tax revenue		227			211			873			787
Investment income		61			13			143			52
Other revenue		18			19			75			77
Total revenue		8,223			7,409			31,974			27,771
Operating expenses:
Medical care costs		6,992			6,362			27,175			23,704
General and administrative expenses		629			579			2,311			2,068
Premium tax expenses		227			211			873			787
Depreciation and amortization		47			35			176			131
Impairment		208			—			208			—
Other		15			31			58			61
Total operating expenses		8,118			7,218			30,801			26,751
Operating income		105			191			1,173			1,020
Other expenses, net:
Interest expense		27			30			110			120
Other expense, net		—			25			—			25
Total other expenses, net		27			55			110			145
Income before income tax expense		78			136			1,063			875
Income tax expense		22			33			271			216
Net income	$	56		$	103		$	792		$	659

Net income per share – Diluted	$	0.96		$	1.74		$	13.55		$	11.25

Diluted weighted average shares outstanding		58.4			58.7			58.5			58.6

Operating Statistics:
Medical care ratio		88.3	%		88.8	%		88.0	%		88.3	%
G&A ratio		7.6	%		7.8	%		7.2	%		7.4	%
Premium tax ratio		2.8	%		2.9	%		2.7	%		2.8	%
Effective income tax rate		28.5	%		24.2	%		25.5	%		24.7	%
After-tax margin		0.7	%		1.4	%		2.5	%		2.4	%

MOLINA HEALTHCARE, INC.
CONSOLIDATED BALANCE SHEETS
	December 31,
	2022			2021
	Unaudited
	*(Dollars in millions,* *except per-share amounts)*
ASSETS
Current assets:
Cash and cash equivalents	$	4,006		$	4,438
Investments		3,499			3,202
Receivables		2,302			2,177
Prepaid expenses and other current assets		277			247
Total current assets		10,084			10,064
Property, equipment, and capitalized software, net		259			396
Goodwill and intangible assets, net		1,390			1,252
Restricted investments		238			212
Deferred income taxes		220			106
Other assets		123			179
Total assets	$	12,314		$	12,209

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Medical claims and benefits payable	$	3,528		$	3,363
Amounts due government agencies		2,079			2,472
Accounts payable, accrued liabilities and other		889			842
Deferred revenue		359			370
Total current liabilities		6,855			7,047
Long-term debt		2,176			2,173
Finance lease liabilities		215			219
Other long-term liabilities		104			140
Total liabilities		9,350			9,579
Stockholders’ equity:
Common stock, $0.001 par value, 150 million shares authorized; outstanding: 58 million shares at each of December 31, 2022 and December 31, 2021		—			—
Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding		—			—
Additional paid-in capital		328			236
Accumulated other comprehensive loss		(160	)		(5	)
Retained earnings		2,796			2,399
Total stockholders’ equity		2,964			2,630
Total liabilities and stockholders’ equity	$	12,314		$	12,209

MOLINA HEALTHCARE, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
	Year Ended
	December 31,
	2022			2021

	*(In millions)*
Operating activities:
Net income	$	792		$	659
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		176			131
Deferred income taxes		(66	)		(24	)
Share-based compensation		103			72
Loss on debt repayment		—			25
Impairment		208			—
Other, net		8			33
Changes in operating assets and liabilities:
Receivables		(95	)		(415	)
Prepaid expenses and other current assets		(124	)		(19	)
Medical claims and benefits payable		153			471
Amounts due government agencies		(428	)		1,046
Accounts payable, accrued liabilities and other		55			138
Deferred revenue		(11	)		(5	)
Income taxes		2			7
Net cash provided by operating activities		773			2,119
Investing activities:
Purchases of investments		(1,913	)		(2,713	)
Proceeds from sales and maturities of investments		1,398			1,329
Net cash paid in business combinations		(134	)		(129	)
Purchases of property, equipment, and capitalized software		(91	)		(77	)
Other, net		(50	)		(63	)
Net cash used in investing activities		(790	)		(1,653	)
Financing activities:
Common stock purchases		(400	)		(128	)
Common stock withheld to settle employee tax obligations		(54	)		(53	)
Contingent consideration liabilities settled		(20	)		(20	)
Proceeds from senior notes offering, net of issuance costs		—			740
Repayment of senior notes		—			(723	)
Other, net		33			1
Net cash used in financing activities		(441	)		(183	)
Net (decrease) increase in cash, cash equivalents, and restricted cash and cash equivalents		(458	)		283
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period		4,506			4,223
Cash, cash equivalents, and restricted cash and cash equivalents at end of period	$	4,048		$	4,506

MOLINA HEALTHCARE, INC.
UNAUDITED SEGMENT DATA
*(Dollars in millions)*

	December 31,
	2022	2021
Ending Membership by Segment:
Medicaid	4,754,000	4,329,000
Medicare	156,000	142,000
Marketplace	348,000	728,000
Total	5,258,000	5,199,000

	Three Months Ended December 31,
	2022						2021
	Premium Revenue		Medical Margin		MCR ⁽¹⁾		Premium Revenue		Medical Margin		MCR ⁽¹⁾
	Premium Revenue		Medical Margin		MCR ⁽¹⁾		Premium Revenue		Medical Margin		MCR ⁽¹⁾
Medicaid	$	6,421	$	813	87.3	%	$	5,441	$	635	88.3	%
Medicare		948		77	91.8			873		101	88.3
Marketplace		548		35	93.8			852		68	92.1
Consolidated	$	7,917	$	925	88.3	%	$	7,166	$	804	88.8	%


	Year Ended December 31,
	2022						2021
	Premium Revenue		Medical Margin		MCR ⁽¹⁾		Premium Revenue		Medical Margin		MCR ⁽¹⁾
	Premium Revenue		Medical Margin		MCR ⁽¹⁾		Premium Revenue		Medical Margin		MCR ⁽¹⁾
Medicaid	$	24,827	$	2,981	88.0	%	$	20,461	$	2,322	88.7	%
Medicare		3,795		437	88.5			3,361		430	87.2
Marketplace		2,261		290	87.2			3,033		399	86.9
Consolidated	$	30,883	$	3,708	88.0	%	$	26,855	$	3,151	88.3	%

(1) The MCR represents medical costs as a percentage of premium revenue.

MOLINA HEALTHCARE, INC.

CHANGE IN MEDICAL CLAIMS AND BENEFITS PAYABLE

(Dollars in millions)

The Company’s claims liabilities include additional reserves to account for moderately adverse conditions based on historical experience and other factors including, but not limited to, variations in claims payment patterns, changes in utilization and cost trends, known outbreaks of disease, and large claims. The Company’s reserving methodology is consistently applied across all periods presented. The amounts displayed for “Components of medical care costs related to: Prior year” represent the amounts by which the original estimates of claims and benefits payable at the beginning of the year were more than the actual liabilities based on information (principally the payment of claims) developed since those liabilities were first reported. The following table presents the components of the change in medical claims and benefits payable for the periods indicated:

	Year Ended
	December 31,
	2022			2021

	Unaudited
Medical claims and benefits payable, beginning balance	$	3,363		$	2,696
Components of medical care costs related to:
Current year		27,459			23,943
Prior year		(284	)		(239	)
Total medical care costs		27,175			23,704
Payments for medical care costs related to:
Current year		24,345			21,148
Prior year		2,670			2,080
Total paid		27,015			23,228
Acquired balances, net of post-acquisition adjustments		12			197
Change in non-risk and other provider payables		(7	)		(6	)
Medical claims and benefits payable, ending balance	$	3,528		$	3,363

Days in Claims Payable ⁽¹⁾		47			51

__________________

(1)

The Company calculates Days in Claims Payable using claims incurred but not paid, or IBNP, and other fee-for-service payables included in medical claims and benefits payable, and quarterly fee-for-service related costs included in medical care costs within the Company’s consolidated financial statements.

MOLINA HEALTHCARE, INC.

RECONCILIATION OF UNAUDITED NON-GAAP FINANCIAL MEASURES

(In millions, except per diluted share amounts)

The Company believes that certain non-GAAP (generally accepted accounting principles) financial measures are useful supplemental measures to investors in comparing the Company’s performance to the performance of other public companies in the health care industry. The non-GAAP financial measures are also used internally to enable management to assess the Company’s performance consistently over time. These non-GAAP financial measures, presented below, should be considered as supplements to, and not as substitutes for or superior to, GAAP measures.

Adjustments represent additions and deductions to GAAP net income as indicated in the table below, which include the non-cash impact of amortization of acquired intangible assets, acquisition-related expenses, and the impact of certain expenses and other items that management believes are not indicative of longer-term business trends and operations.

Adjusted G&A Ratio represents the GAAP G&A ratio, recognizing adjustments.

Adjusted net income represents GAAP net income recognizing the adjustments, net of tax. The Company believes that adjusted net income is helpful to investors in assessing the Company’s financial performance.

Adjusted net income per diluted share represents adjusted net income divided by weighted average common shares outstanding on a fully diluted basis.

Adjusted after-tax margin represents adjusted net income, divided by total revenue.

	Three Months Ended December 31,												Year Ended December 31,
	2022						2021						2022						2021
	Amount			Per Diluted Share			Amount			Per Diluted Share			Amount			Per Diluted Share			Amount			Per Diluted Share
Net income	$	56		$	0.96		$	103		$	1.74		$	792		$	13.55		$	659		$	11.25
Adjustments:
Impairment	$	208		$	3.57		$	—		$	—		$	208		$	3.56		$	—		$	—
Amortization of intangible assets		21			0.35			14			0.23			77			1.32			49			0.83
Acquisition-related expenses ⁽¹⁾		11			0.18			49			0.84			49			0.83			93			1.59
Loss on debt repayment		—			—			25			0.43			—			—			25			0.43
Other ⁽²⁾		—			—			—			—			—			—			9			0.16
Subtotal, adjustments		240			4.10			88			1.50			334			5.71			176			3.01
Income tax effect		(56	)		(0.96	)		(21	)		(0.36	)		(78	)		(1.34	)		(42	)		(0.72	)
Adjustments, net of tax		184			3.14			67			1.14			256			4.37			134			2.29
Adjusted net income	$	240		$	4.10		$	170		$	2.88		$	1,048		$	17.92		$	793		$	13.54

__________________

(1)		Reflects non-recurring costs associated with acquisitions, including various transaction and certain integration costs.
(2)		The year ended December 31, 2022 includes gain on lease termination and disposal of fixed assets. The year ended December 31, 2021 includes change in premium deficiency reserves, loss on sale of property, and restructuring costs.

MOLINA HEALTHCARE, INC.
RECONCILIATION OF UNAUDITED NON-GAAP FINANCIAL MEASURES (CONTINUED)
2023 GUIDANCE

	Amount			Per Diluted Share ⁽²⁾
Net income	$	1,077		$	18.53
Adjustments:
Amortization of intangible assets		92			1.58
Acquisition-related expenses		1			0.02
Subtotal, adjustments		93			1.60
Income tax effect ⁽¹⁾		(22	)		(0.38	)
Adjustments, net of tax		71			1.22
Adjusted net income per diluted share	$	1,148		$	19.75

__________________

(1)		Income tax effect calculated at the statutory tax rate of approximately 23.7%.
(2)		Computations assume approximately 58.1 million diluted weighted average shares outstanding.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230208005859/en/

Contacts

Investor Contact: Joseph Krocheski, Joseph.Krocheski@molinahealthcare.com, 562-951-8382

Media Contact: Caroline Zubieta, Caroline.Zubieta@molinahealthcare.com, 562-951-1588